Related Experiment Video
Updated: Jul 15, 2025
Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
Published on: March 10, 2020
A Hospital-Based Study on Congenital Heart Defects - Haidian District, Beijing Municipality, China, 2013-2022
Yaxian Wu1,2, Chao Meng3, Jufen Liu1,2
1Institute of Reproductive and Child Health / National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing, China.
Insights
Congenital heart defects (CHDs) are increasing in China, driven by better diagnostics for minor defects. Despite improved detection, survival rates for CHDs have not improved, necessitating policy changes.
Area of Science:
- Pediatrics
- Public Health
- Cardiology
Background:
- Congenital heart defects (CHDs) are the most common birth defects in China, associated with high mortality and morbidity.
- Recent trends indicate a rise in CHD occurrence, underscoring the need for focused research.
Purpose of the Study:
- To analyze the birth prevalence and trends of CHDs in Haidian District from 2013 to 2022.
- To evaluate the impact of diagnostic advancements on CHD detection and survival rates.
Main Methods:
- Retrospective analysis of CHD data from Haidian District, China (2013-2022).
- Examination of birth prevalence rates and trends in congenital heart defects.
Main Results:
- The cumulative birth prevalence of CHDs was 80.77 per 10,000 births.
- An upward trend in CHDs was observed, primarily due to increased diagnosis of minor, non-critical defects (non-CCHDs) attributed to advanced diagnostics.
- Survival rates for CHDs did not show a corresponding improvement despite enhanced detection.
Conclusions:
- Policy formulation is essential for graded management of CHDs.
- Diagnostic criteria require timely updates to reflect technological advancements.
- Enhanced post-diagnosis medical consultation is crucial for cases not requiring therapeutic abortion.
What Is Already Known About This Topic?:
Congenital heart defects (CHDs) represent the most prevalent birth defects in China, exhibiting significant mortality and morbidity rates. Recent years have witnessed a steady increase in the occurrence of CHDs, highlighting a crucial need for rigorous research focus.
What Is Added By This Report?:
The cumulative birth prevalence of CHDs in Haidian District from 2013 to 2022 was 80.77 per 10,000 births, reflective of an upward trend primarily influenced by the diagnosis of minor, non-critical congenital defects (non-CCHDs). This increase can be attributed to advancements in diagnostic methodologies. Despite the progress in detection, the survival rate for CHDs did not correspondingly improve.
What Are The Implications For Public Health Practice?:
Policies need to be formulated to promote the graded management of CHDs. There should be timely updates to the diagnostic criteria to align with advancements in diagnostic techniques. Moreover, in instances where therapeutic abortion is not required, the provision of appropriate medical consultation post-diagnosis should be enhanced.
